Katti Jessen Email & Phone Number

Senior Vice President, Translational Sciences @ Solve Therapeutics, Inc.

5 free lookups per month.

Katti Jessen's Location

San Diego County, California, United States

Katti Jessen's Work

Senior Vice President, Translational Sciences @ Solve Therapeutics, Inc.
Executive Director, Translational Research, Oncology R and D @ VelosBio Inc. (acquired by Merck)
Executive Director, Translational Science, Oncology Clinical Research and Development @ Oncternal Therapeutics

Director, Translational Oncology, Early Oncology Development and Clinical Research @ Pfizer
Associate Director, Oncology Drug Discovery and Development @ eFFECTOR Therapeutics, Inc.
Associate Director, Oncology Translational Research @ Takeda Oncology
Group Leader, Oncology Discovery and Development @ Intellikine Inc
Senior Scientist, Discovery Biology, Oncology @ SGX Pharmaceuticals (acquired by Eli Lilly)
Scientist - Oncology Drug Discovery @ Maxim Pharmaceuticals (acquired by Epicept)
Post Doc @ Sanford Burnham Prebys Medical Discovery Institute

see less

Katti Jessen's Education

University of California, Davis
Ph.D. (Molecular and Cellular Biology)
University of California, Davis
B.S. (Major: Biochemistry, Minor: German)

Katti Jessen's Skills

Pharmacology
Drug Discovery
Assay Development

In Vitro
Cell Biology
Molecular Biology
In Vivo
Biochemistry
Biomarkers
Biotechnology

see less

Katti Jessen's Summary

Katti Jessen, based in San Diego County, California, United States, is currently a Senior Vice President, Translational Sciences at Solve Therapeutics, Inc., bringing experience from previous roles at VelosBio Inc. (acquired by Merck), Oncternal Therapeutics, Pfizer and eFFECTOR Therapeutics, Inc.. Katti Jessen holds a Ph.D. in Molecular and Cellular Biology @ University of California, Davis. With a robust skill set that includes Pharmacology, Drug Discovery, Assay Development, In Vitro, Cell Biology and more, Katti Jessen contributes valuable insights to the industry. Katti Jessen has 2 emails on RocketReach.